Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2012 Financial and Operating Results

FFO Per Share - Diluted of $1.08 and $3.18 for Three and Nine Months Ended 3Q12

EPS − Diluted of $0.17 and $0.75 for Three and Nine Months Ended 3Q12

Significant Progress Converting Non-Income-Producing Assets into Income-Producing Operating Assets

******* This earnings release was initially released on October 26, 2012, and re-released on October 29, 2012, without modification. *******

29 Oct, 2012, 08:30 ET from Alexandria Real Estate Equities, Inc.

PASADENA, Calif., Oct. 26, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the third quarter ended September 30, 2012.

Third Quarter Ended September 30, 2012, Highlights

Results

  • Funds From Operations ("FFO") Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $67.1 Million, or $1.08 Per Share;  FFO Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $196.8 Million, or $3.18 Per Share
  • Adjusted Funds From Operations ("AFFO") Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $65.0 Million, or $1.04 Per Share;  AFFO Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $191.4 Million, or $3.09 Per Share
  • Net Income Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $10.6 Million, or $0.17 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $18.8 Million, or $0.30 Per Share;  Net Income Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $46.6 Million, or $0.75 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, Excluding $2.2 Million, or $0.03 Per Share, Related to Loss on Early Extinguishment of Debt, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $57.0 Million, or $0.91 Per Share 

Core Operating Metrics

  • Total Revenues for the Three Months Ended September 30, 2012, were $145.5 Million, Compared to Total Revenues for the Three Months Ended September 30, 2011, of $138.1 Million; Total Revenues for the Nine Months Ended September 30, 2012, were $431.9 Million, Compared to Total Revenues for the Nine Months Ended September 30, 2011, of $409.0 Million
  • Net Operating Income ("NOI") for the Three Months Ended September 30, 2012, was $100.8 Million, Compared to NOI for the Three Months Ended September 30, 2011, of $97.2 Million; NOI for the Nine Months Ended September 30, 2012, was $304.0 Million, Compared to NOI for the Nine Months Ended September 30, 2011, of $291.0 Million
  • Operating Margins at 69% for the Three Months Ended September 30, 2012
  • Cash and GAAP Same Property Net Operating Income Increase of 4.3% and Decrease of 0.9%, Respectively, for the Three Months Ended September 30, 2012
  • Cash and GAAP Same Property Net Operating Income Increase of 2.6% and Decrease of 0.8%, Respectively, for the Nine Months Ended September 30, 2012
  • 48% of Annualized Base Rent from Investment-Grade Client Tenants
  • During the Three Months Ended September 30, 2012, Executed 47 Leases for 732,000 Rentable Square Feet, Including 266,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 2.9% and Increase of 7.6% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space
  • During the Nine Months Ended September 30, 2012, Executed 146 Leases for 2,603,000 Rentable Square Feet, Including 829,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 1.9% and Increase of 5.9% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space; Excluding One Lease for 48,000 Rentable Square Feet Related to One Client Tenant in the Research Triangle Park Market and One Lease for 71,000 Rentable Square Feet Related to One Client Tenant in the Suburban Washington, D.C. Market, Rental Rates for Renewed/Re-Leased Space were, on Average, 0.1% Higher and 7.3% Higher than Rental Rates for Expiring Leases on a Cash and GAAP Basis, Respectively
  • Occupancy Percentage for North America Operating Properties of 94.2% and Occupancy Percentage for North America Operating and Redevelopment Properties of 90.0%; Occupancy Percentage for All Operating Properties of 93.0%, Including Asia Properties, and Occupancy Percentage for All Operating and Redevelopment Properties of 88.3%, Including Asia Properties

Value-Added Opportunities and External Growth

  • From November 2011 to September 2012, Completed Redevelopment of 10300 Campus Point Drive, Located in the San Diego Market, a 96% Leased Project with 279,138 Rentable Square Feet, Including the Completion of 189,562 Rentable Square Feet in September 2012
  • In September 2012, Completed Development of 4755 Nexus Center Drive, Located in the San Diego Market, a 100% Leased Project with 45,255 Rentable Square Feet
  • In June 2012, Completed Redevelopment of 3530/3550 John Hopkins Court, Located in the San Diego Market, a 100% Leased Project with 98,320 Rentable Square Feet
  • In April 2012, Completed Development Located in the Canadian Market, a 100% Leased Project with 26,426 Rentable Square Feet
  • In April 2012, Commenced Unconsolidated Joint Venture Development of 360 Longwood Avenue, Located in the Greater Boston Market, a 37% Pre-Leased Project with 414,000 Rentable Square Feet
  • In January 2012, Commenced Development of 259 East Grand Avenue, Located in the San Francisco Bay Market, a 100% Pre-Leased Building with 170,618 Rentable Square Feet

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

Significant Balance Sheet Milestones

  • Completed $75.1 Million of Asset Sales Year to Date with Additional $34.0 Million of Land Sales Forecasted in Fourth Quarter 2012 for a Total of $109.1 Million; Additional $84.5 Million Sales of Income-Producing Assets in Process
  • Established an "At The Market" Common Stock Offering Program Under Which We May Sell Up to $250.0 Million of Our Common Stock; and Raised $98.4 Million in Net Proceeds from Sales Under This Program for the Nine Months Ended September 30, 2012, including $58.5 Million in Net Proceeds from Sales Under This Program for the Three Months Ended September 30, 2012
  • In June 2012, Closed a Secured Construction Loan with Aggregate Commitments of $55 Million for a Development Project at 259 East Grand Avenue located in the San Francisco Bay Market
  • In April 2012, Amended Our $1.5 Billion Unsecured Senior Line of Credit to Reduce Its Interest Rate and Extend Its Maturity Date to April 2017, Assuming We Exercise Our Sole Right to Extend the Maturity Date Twice
  • In April 2012, Redeemed All $129.6 Million of Our Outstanding 8.375% Series C Preferred Stock
  • In March 2012, Completed a 6.45% Series E Preferred Stock Offering with Net Proceeds of $124.9 Million
  • In February 2012, Completed Our Debut 4.60% Unsecured Senior Notes Offering with Net Proceeds of $544.6 Million; Net Proceeds from the Offering Were Used to Repay Certain Outstanding Variable Rate Bank Debt
  • In February 2012, Repaid All $250 Million of Our 2012 Unsecured Senior Bank Term Loan
  • In January and April 2012, Retired All $84.8 Million of Our 3.70% Unsecured Senior Convertible Notes

Events Subsequent to Quarter End

  • In the Fourth Quarter of 2012, We Expect to Commence Vertical Construction of the Ground-Up Development of 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City, a Project with 419,806 Rentable Square Feet Located in the Greater NYC Market

VALUE-ADDED OPPORTUNITIES AND EXTERNAL GROWTH

Development and redevelopment

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.  Our initial stabilized yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our contractual cash rents related to our value-added projects to increase over time.  Initial stabilized yield is calculated as the quotient of net operating income and our investment in the property at stabilization ("Initial Stabilized Yield").

During the three and nine months ended September 30, 2012, we executed leases aggregating 266,000 and 829,000 rentable square feet, respectively, related to our development and redevelopment projects.

In the fourth quarter of 2012, we expect to commence a ground-up development of a multi-tenant laboratory building with 419,806 rentable square feet at 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City.  We expect to provide an estimate of our Initial Stabilized Yields next quarter upon commencement of ground-up development.

From November 2011 to September 2012, we completed the redevelopment of 279,138 rentable square feet, including the completion of 189,562 rentable square feet in September 2012, at 10300 Campus Point Drive, located in the San Diego market.  This property is a multi-tenant campus with 449,759 rentable square feet that is 96% leased to (1) Eli Lilly and Company, (2) The Regents of the University of California, (3) Celgene Corporation, and (4) Covance Inc.  The Initial Stabilized Yield on a cash and GAAP basis for the 279,138 rentable square feet redevelopment project was approximately 7.9% and 7.7%, respectively.

In September 2012, we completed the development of 4755 Nexus Center Drive, located in the San Diego market, a single-tenant building with 45,255 rentable square feet that is 100% leased to Optimer Pharmaceuticals, Inc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 6.8% and 7.5%, respectively.

In June 2012, we completed the redevelopment of 3530/3550 John Hopkins Court, located in the San Diego market, a multi-tenant campus with 98,320 rentable square feet that is 100% leased to (1) Genomics Institute of the Novartis Research Foundation, a non-profit research institute, and (2) a leading industrial biotechnology company.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 8.9% and 9.1%, respectively.

In April 2012, we completed the development of a building located in the Canadian market with 26,426 rentable square feet that is 100% leased to GlaxoSmithKline plc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 7.7% and 8.3%, respectively. 

In April 2012, we commenced ground-up development of 360 Longwood Avenue, located in the Longwood Medical Area of the Greater Boston market, our 414,000 rentable square feet unconsolidated joint venture development project that is 37% pre-leased to the Dana-Farber Cancer Institute, Inc.  Dana-Farber Cancer Institute, Inc. also has an option to lease an additional two floors of approximately 99,000 rentable square feet, or an additional 24% of the total rentable square feet of the project.  We expect to achieve an unlevered Initial Stabilized Yield on a cash and GAAP basis in a range from 8.1% to 8.5% and 8.7% to 9.1%, respectively.  Funding for this project is provided primarily by capital from our joint venture partner and a $213.2 million non-recourse secured construction loan.  Additionally, our share of the future funding is expected to be less than the $22.3 million distribution we received in March 2012, upon admittance of the new partner and refinancing of the project.

In January 2012, we commenced a ground-up development of a single-tenant building with 170,618 rentable square feet at 259 East Grand Avenue, located in the San Francisco Bay market, which is 100% pre-leased to Onyx Pharmaceuticals Inc.  We expect to achieve an Initial Stabilized Yield on both a cash and GAAP basis for this property in a range from 7.8% to 8.2%.  Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

Acquisitions

In April 2012, we acquired 3013/3033 Science Park Road located in the San Diego market, which consists of two life science laboratory buildings aggregating 176,500 rentable square feet, for approximately $13.7 million.  The property was 100% leased on a short-term basis, and thereafter, we expect to redevelop approximately 98,000 rentable square feet.  The remaining square footage will be classified as future developable square feet once the existing client tenant vacates.  We expect to provide an estimate of our Initial Stabilized Yields in the future upon commencement of development/redevelopment activity.

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Tabular dollar amounts in thousands, except per square foot amounts)

(Unaudited)

SIGNIFICANT BALANCE SHEET MILESTONES

Real estate asset sales

In September 2012, four properties aggregating 504,130 rentable square feet met the classification requirements for held for sale.  The current buyers are expected to reposition these assets and/or incur significant investments to re-tenant the properties.  During the three months ended September 30, 2012, we recorded impairment charges aggregating approximately $9.8 million to reduce the aggregate carrying value of the properties to the estimated sales price less costs to sell.

 

Rentable/

Sales

Occupancy

Annualized

Date

Developable

Price

at Date

GAAP

Sales

Gain

Description

Location

of Sale

Square Feet

per SF

of Sale

NOI (1)

Price (2)

on Sale

Land parcels and assets with a previous operating

     component:

1201/1209 Mercer Street (3)

Seattle

September 2012

76,029

$           73

0%

$           45

$      5,570

$           54

801 Dexter Avenue North (3)

Seattle

August 2012

120,000

$           72

0%

$          (96)

8,600

$           55

Land parcel

Greater Boston

March 2012

(4)

$         275

N/A

          N/A

31,360

$      1,864

Sale of land parcels and assets with a previous

     operating component

45,530

Income-producing properties:

200 Lawrence Drive/210 Welsh Pool Road

Pennsylvania

July 2012

210,866

$           94

100%

$       2,193

19,750

(5)

$         103

155 Fortune Boulevard (6)

Route 495/Worcester

July 2012

36,000

$         222

100%

$         804

8,000

$      1,350

5110 Campus Drive (6)

Pennsylvania

May 2012

21,000

$           86

71%

$           77

1,800

$            2

Sales of income-producing properties

29,550

(7)

Completed sales subtotal

75,080

Sales in process

Various

Pending

261,000

$         130

N/A

$        (470)

34,000

(8)

TBD

Subtotal

109,080

Other incremental dispositions

Sales in process (9)

Various

Pending

504,130

$         174

N/A

$     12,798

84,500

TBD

Total projected dispositions

$   193,580

 

(1)       Annualized using actual year to date results as of the quarter end prior to date of sale or September 30, 2012.

(2)       Represents contractual sales price for assets sold or contractual/estimated sale price for sales in process.

(3)       Properties sold to residential developers.

(4)       In March 2012, we sold one-half of our 55% interest in a land parcel supporting a 414,000 rentable square feet project for approximately $31.4 million, or approximately $275 per rentable square foot.

(5)       Sales price reflects the near-term lease expiration of a client tenant occupying 38,513 rentable square feet, or 18% of the total rentable square feet, on the date of sale.  In connection with the sale, we received an interest-only secured note receivable for $6.1 million due in 2018.

(6)       Properties were sold to client tenants. 

(7)       The weighted average capitalization rate (Annualized GAAP NOI divided by Sales Price) related to sales of income-producing assets in the nine months ended September 30, 2012, was 10.4%.

(8)       Includes a $13.3 million amortizing secured note receivable due in 2014.

(9)       Includes four properties, which the buyers expect to renovate.  During the three months ended September 30, 2012, we recognized an aggregate charge for impairment of real estate of approximately $9.8 million to adjust the carrying values of the four properties to their fair value, less costs to sell.  We may receive a note receivable in connection with sale of one property.  One sale ranging from $42 million to $47 million may close during the three months ended December 31, 2012. 

Sale of land parcel

In March 2012, we contributed our 55% ownership interest in a land parcel supporting a future building with 414,000 rentable square feet in the Longwood Medical Area of the Greater Boston market to a newly formed joint venture (the "Restated JV") with National Development and Charles River Realty Investors, and admitted as a 50% member, Clarion Partners, LLC, resulting in a reduction of our ownership interest from 55% to 27.5%.  The transfer of one-half of our 55% ownership interest in this real estate venture to Clarion Partners, LLC, was accounted for as an in-substance partial sale of an interest in the underlying real estate.  In connection with the sale of one-half of our 55% ownership interest in the land parcel, we received a special distribution of approximately $22.3 million, which included the recognition of a $1.9 million gain on sale of land and approximately $5.4 million from our share of loan refinancing proceeds.  The land parcel we sold in March 2012 did not meet the criteria for discontinued operations since the parcel did not have any significant operations prior to disposition. Pursuant to the presentation and disclosure literature on gains/losses on sales or disposals by REITs required by the Securities and Exchange Commission ("SEC"), gains or losses on sales or disposals by a REIT that do not qualify as discontinued operations are classified below (loss) income from discontinued operations in the income statement.  Accordingly, we classified the $1.9 million gain on sale of land below (loss) income from discontinued operations, net, in the condensed consolidated statements of income.  Our 27.5% share of the land was sold at approximately $31 million (including closing costs), or approximately $275 per rentable square foot.  Upon formation of the Restated JV, the existing $38.4 million secured loan was refinanced with a seven-year (including two one-year extension options) non-recourse $213 million secured construction loan with initial loan proceeds of $50 million.  As of September 30, 2012, the outstanding balance on the construction loan was $56.4 million.  We do not expect our share of capital contributions through the completion of the project to exceed the approximate $22.3 million in net proceeds received in this transaction.  Construction of this $350 million project commenced in April 2012.  The initial occupancy date for this project is expected to be in the fourth quarter of 2014.  The project is 37% pre-leased to Dana-Farber Cancer Institute, Inc.  In addition, Dana-Farber Cancer Institute, Inc. has an option to lease an additional two floors approximating 99,000 rentable square feet, or 24% of the total rentable square feet of the project.  In addition to our economic share of the joint venture, we also expect to earn development and other fees of approximately $3.5 million through 2015, and recurring annual property management fees thereafter, from this project.

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

"At the market" common stock offering program

In June 2012, we established an "at the market" common stock offering program under which we may sell, from time to time, up to an aggregate of $250.0 million of our common stock through our sales agents, BNY Mellon Capital Markets, LLC and Credit Suisse Securities (USA) LLC, during a three-year period.  During the nine months ended September 30, 2012, we sold an aggregate of 1,366,977 shares of common stock for gross proceeds of approximately $100.0 million at an average stock price of $73.15 and net proceeds of approximately $98.4 million.  This includes the sale of an aggregate of 793,291 shares of common stock for gross proceeds of approximately $59.5 million at an average stock price of $74.97 and net proceeds of approximately $58.5 million during the three months ended September 30, 2012.  As of September 30, 2012, approximately $150.0 million of our common stock remained available for issuance under the "at the market" common stock offering program.

Secured construction loan for development project in San Francisco Bay market

In June 2012, we closed a secured construction loan with aggregate commitments of $55 million.  The construction loan matures in July 2015, and we have an option to extend the stated maturity date of July 1, 2015, by one year, twice, to July 1, 2017.  The construction loan will be used to fund the majority of the cost to complete the development of a 100% pre-leased life science laboratory building with 170,618 rentable square feet at 259 East Grand Avenue in the San Francisco Bay market.  The construction loan bears interest at the London Interbank Offered Rate ("LIBOR") or the base rate specified in the construction loan agreement, defined as the higher of either the prime rate being offered by our lender or the federal funds rate in effect on the day of borrowing ("Base Rate"), plus in either case a specified margin of 1.50% for LIBOR borrowings or 0.25% for Base Rate borrowings.  As of September 30, 2012, commitments of $53.0 million were available.

Debut 4.60% unsecured senior notes payable offering

In February 2012, we completed the issuance of our 4.60% unsecured senior notes payable due in February 2022.  Net proceeds of approximately $544.6 million were used to repay certain outstanding variable rate bank debt, including the entire $250 million of our 2012 unsecured senior bank term loan ("2012 Unsecured Senior Bank Term Loan"), and approximately $294.6 million of outstanding borrowings under our unsecured senior line of credit.  In connection with the retirement of our 2012 Unsecured Senior Bank Term Loan, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees for the three months ended March 31, 2012.

Retirement of 3.70% unsecured senior convertible notes

During January 2012, we repurchased approximately $83.8 million in principal amount of our 3.70% unsecured senior convertible notes ("3.70% Unsecured Senior Convertible Notes") at par, pursuant to options exercised by holders thereof under the indenture governing the notes.  During April 2012, we repurchased the remaining outstanding $1.0 million in principal amount of the notes.  In aggregate, we repurchased approximately $84.8 million in principal amount of the notes and we did not recognize a gain or loss as a result during the six months ended June 30, 2012.

Amendment of $1.5 billion unsecured senior line of credit

In April 2012, we amended our $1.5 billion unsecured senior line of credit with Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., and Citigroup Global Markets Inc. as joint lead arrangers, and certain lenders, to extend the maturity date of our unsecured senior line of credit, provide an accordion option for up to an additional $500 million, and reduce the interest rate for outstanding borrowings.  The maturity date of the unsecured senior line of credit was extended to April 2017, assuming we exercise our sole right to extend the stated maturity date twice by an additional six months after each exercise.  Borrowings under the unsecured senior line of credit bear interest at LIBOR or the base rate specified in the amended unsecured senior line of credit agreement, plus in either case a specified margin (the "Applicable Margin").  The Applicable Margin for LIBOR borrowings under the unsecured senior line of credit was set at 1.20%, down from 2.40% in effect immediately prior to the modification.  In addition to the Applicable Margin, our unsecured senior line of credit is subject to an annual facility fee of 0.25%.  In connection with the modification of our unsecured senior line of credit in April 2012, we recognized a loss on early extinguishment of debt of approximately $1.6 million related to the write-off of a portion of unamortized loan fees for the three months ended June 30, 2012.

6.45% series E preferred stock offering

In March 2012, we completed a public offering of 5,200,000 shares of our 6.45% series E cumulative redeemable preferred stock ("Series E Preferred Stock").  The shares were issued at a price of $25.00 per share, resulting in net proceeds of approximately $124.9 million (after deducting underwriters' discounts and other offering costs).  The proceeds were initially used to reduce the outstanding borrowings under our unsecured senior line of credit.  We then borrowed funds under our unsecured senior line of credit to redeem our 8.375% series C cumulative redeemable preferred stock ("Series C Preferred Stock") in April 2012.  The dividends on our Series E Preferred Stock are cumulative and accrue from the date of original issuance.  We pay dividends quarterly in arrears at an annual rate of 6.45%, or $1.6125 per share.  Our Series E Preferred Stock has no stated maturity date, is not subject to any sinking fund or mandatory redemption provisions, and is not redeemable before March 15, 2017, except to preserve our status as a REIT.  On and after March 15, 2017, we may, at our option, redeem the Series E Preferred Stock, in whole or in part, at any time for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends on the Series E Preferred Stock up to, but excluding, the redemption date.  In addition, upon the occurrence of a change of control, we may, at our option, redeem the Series E Preferred Stock, in whole or in part within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends up to, but excluding, the date of redemption.  Investors in our Series E Preferred Stock generally have no voting rights.

8.375% series C preferred stock redemption

In April 2012, we redeemed all 5,185,500 outstanding shares of our Series C Preferred Stock at a price equal to $25.00 per share, or approximately $129.6 million in aggregate, and paid $0.5234375 per share, representing accumulated and unpaid dividends to the redemption date on such shares.  We recognized a charge of approximately $6.0 million to net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders in March 2012, related to the write-off of original issuance costs of the Series C Preferred Stock.

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

GUIDANCE

Earnings outlook

Based on our current view of existing market conditions and certain current assumptions, we expect that our earnings per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – diluted and FFO per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – diluted for the year ended December 31, 2012, will be as set forth in the table below.  The table below provides a reconciliation of FFO per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – diluted, as adjusted, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure.

 

Guidance for the Year Ended December 31, 2012

Reported on October 26, 2012

Reported on July 30, 2012

    Earnings per share attributable to Alexandria Real Estate Equities, Inc.'s common

        stockholders – diluted

$1.16 - $1.26

$1.36 - $1.46

    Depreciation and amortization

$3.00 - $3.06

$2.93 - $2.99

      Gain on sales of property

$ (0.06)

$ (0.03)

    Impairment of real estate

$0.16

    FFO per share attributable to Alexandria Real Estate Equities, Inc.'s common

        stockholders – diluted

$4.32 - $4.36

$4.32 - $4.36

Write-off of unamortized loan fees upon early retirement of the 2012 Unsecured Senior

       Bank Term Loan

$0.01

$0.01

Write-off of unamortized loan fees upon modification of unsecured senior line of credit

$0.03

$0.03

Preferred stock redemption charge

$0.10

$0.10

    Realized gain on equity investment primarily related to one non-tenant life science    entity

$ (0.09)

$(0.09)

    FFO per share attributable to Alexandria Real Estate Equities, Inc.'s common    stockholders – diluted, as adjusted

$4.37 - $4.41

$4.37 - $4.41

Key net operating income projection assumptions:

    Same property net operating income growth – cash basis

3% to 4%

3% to 5%

    Same property net operating income growth – GAAP basis

Slightly negative/positive

0% to 2%

    Rental rate steps on lease renewals and re-leasing of space – cash basis

Slightly negative/positive

Slightly negative/positive

    Rental rate steps on lease renewals and re-leasing of space – GAAP basis

Up to 5%

Up to 5%

    Straight-line rents

$6.5 million/qtr

$6.5 million/qtr

    Amortization of above and below market leases

$0.8 million/qtr

$0.8 million/qtr

    Realized gain on equity investment primarily related to one non-tenant life science

        entity

$5.8 million

$5.8 million

 

Net operating income, net income, and FFO for the three months ended December 31, 2012

As of September 30, 2012, we had approximately $304.6 million and $277.5 million of construction in progress related to our five North American development and eight North American redevelopment projects, respectively. The completion of these projects, along with recently delivered projects, certain future projects, and contributions from same properties, are expected to contribute significant increases in rental income, net operating income, and cash flows.  Net operating income from continuing operations is projected to increase from $100.8 million for the three months ended September 30, 2012, to a range from $107.5 million to $109.5 million for the three months ended December 31, 2012 (after considering approximately $3.0 million in required reclassifications for discontinued operations).  Operating performance assumptions related to the completion of our North America development and redevelopment projects, including the timing of initial occupancy, stabilization dates, and Initial Stabilized Yields, are included on page 7.  Certain key assumptions regarding our projections, including the impact of various development and redevelopment projects, are included in the tables above, below, and on the following page. 

The completion of our development and redevelopment projects will result in increased interest expense and other direct project costs, because these project costs will no longer qualify for capitalization and these costs will be expensed as incurred.  Our projections for general and administrative expenses, capitalization of interest, and interest expense, net, are included in the tables on this page.  Our projections of net operating income are subject to a number of variables and uncertainties, including those discussed under the "Forward-looking Statements" section of Part I, the "Risk Factors" section of Item 1A, and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.  Further, we believe net operating income is a key performance indicator and is useful to investors as a performance measure because, when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.

 

Three Months Ended December 31, 2012 (in millions, except per share amounts)

Reported on October 26, 2012

Reported on July 30, 2012

Net operating income:

        Continuing operations                                                                                                                                             

$107.5 - $109.5

$110.5 - $112.5

        Incremental dispositions classified in discontinued operations                                                                                         

$3.0

Total net operating income

$110.5 - $112.5

$110.5 - $112.5

General and administrative

$11.0 - $12.0

$11.0 - $12.0

Capitalization of interest

$13.6 - $14.6

N/A

Interest

$18.0 - $20.0

$19.5 - $22.5

Depreciation and amortization

$42.6 - $47.7

$42.6 - $47.7

Preferred stock dividends

$6.5

$6.5

Other

$1.0 - $1.4

$1.0 - $1.4

Net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders

$26.9 - $30.9

$26.9 - $30.9

FFO

$72.0 - $73.0

$71.1 - $73.0

FFO per share – diluted

$1.15 - $1.17

$1.15 - $1.17

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

Sources and uses of capital

We expect that our principal liquidity needs for the year ended December 31, 2012, will be satisfied by the following multiple sources of capital as shown in the table below.  There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.  Our liquidity available under our unsecured senior line of credit and from cash equivalents was approximately $1.2 billion as of September 30, 2012.

 

Reported on

October 26, 2012

Reported on

July 30, 2012

Sources and Uses of Capital for the Year Ended December 31, 2012 (in millions)

Completed

Projected

Total

Total

Sources of capital:

        Net cash provided by operating activities less dividends

$                     53

$                     28

$                  81

(1)

$                    81

        Asset and land sales

75

                76 - 81

(2)

          151 - 156

112

        Unsecured senior notes payable

550

550

550

        Borrowings on secured construction financing

2

22

24

24

        Series E Preferred Stock issuance

125

125

125

        Issuances under "at the market" common stock offering program

98

(3)

98

40

        Debt, equity, and joint venture capital

51

(4)

                57 - 84

(4)

          108 - 135

236

Total sources of capital

$                   954

$           183 - 215

$   1,137 - 1,169

$                1,168

Uses of capital:

        Development, redevelopment, and construction

$                   429

$                   167

$                596

(5)

$                   646

        Notes receivable from asset and land sales

6

                13 - 45

             19 - 51

        Acquisitions

46

46

46

        Secured debt repayments

8

3

11

(6)

11

        2012 Unsecured Senior Bank Term Loan repayment

250

250

250

        3.70% Unsecured Senior Convertible Notes repurchase

85

85

85

        Series C Preferred Stock redemption

130

130

130

Total uses of capital

$                   954

$           183 - 215

$   1,137 - 1,169

$                1,168

(1)       See table of "Key Net Operating Income Projection Assumptions" and projections table in the "Net Operating Income, Net Income, and FFO for the Three Months Ended December 31, 2012" section on the preceding page.

(2)       Represents an estimate of sources of capital from pending asset and land sales.  As noted in "Real Estate Asset Sales" on page 3, we have other incremental dispositions in process aggregating $84.5 million, a portion of which may close during the three months ended December 31, 2012.

(3)       See "Debt, equity, and joint venture capital."

(4)       Represents an estimate of sources of capital primarily consisting of borrowings under our unsecured senior line of credit and proceeds from our "at the market" common stock offering program.

(5)       See "Investment to Complete" columns in the "Development and Redevelopment Projects in North America" table on the following page for additional details underlying this estimate.  The decrease of approximately $50 million from the approximately $646 million previously reported on July 30, 2012, is primarily attributable to the timing of the spending moving from the three months ended December 31, 2012, to the year ended December 31, 2013.

(6)       Based upon contractually scheduled payments or maturity dates.

 

The key assumptions behind the sources and uses of capital in the table above are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the "Forward-looking statements" section of Part I, the "Risk Factors" section of Item 1A, and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  We expect to update our forecast of sources and uses of capital on a quarterly basis. 

 

Development and Redevelopment Projects in North America

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

Project RSF

Leased Status RSF

Investment

Initial Stabilized

Project

Occu-

Stabili-

Market − Submarket/

In

% Leased/

September 30, 2012

To Complete

Total at

Yield (1)

Start

pancy

zation

Property

Service

CIP

Total

Leased

Negotiating

Marketing

Total

Negotiating

In Service

CIP

2012

Thereafter

Completion

Cash

GAAP

Date

Date

Date

Development projects in North America

Greater Boston – Cambridge

225 Binney Street

303,143

303,143

303,143

303,143

100%

$          −

$   84,163

$     8,788

$   87,322

$   180,273

7.5%

8.1%

4Q11

4Q13

4Q13

San Francisco Bay – Mission Bay

499 Illinois Street (2)

222,780

222,780

222,780

222,780

$          −

$ 111,219

$     2,867

$   39,123

$   153,209

6.4%

7.2%

2Q11

2Q14

1Q15

San Francisco Bay – South SF

259 East Grand Avenue (3)

170,618

170,618

170,618

170,618

100%

$          −

$   45,226

$   13,498

(3)

$   22,137

(3)

$     80,861

7.8-8.2%

7.8-8.2%

1Q12

4Q12

4Q12

400/450 East Jamie Court

99,694

63,342

163,036

127,732

35,304

163,036

78%

$   58,481

$   39,340

$     5,962

$     9,230

$   113,013

4.2%

4.3%

4Q06

3Q11

2Q13

Other - 400/450 East Jamie Court (4)

$   20,659

$  (20,659)

San Diego – University Town Center

5200 Illumina Way

127,373

127,373

127,373

127,373

100%

$          −

$   45,330

$     2,229

$     1,741

$     49,300

7.0%

10.8%

4Q10

4Q12

4Q12

Development projects in North America

99,694

887,256

986,950

728,866

258,084

986,950

74%

$   79,140

$ 304,619

$   33,344

$ 159,553

$   576,656

Redevelopment projects in North America

Greater Boston – Cambridge

400 Technology Square

212,123

212,123

169,939

42,184

212,123

80%

$          −

$ 111,297

$   15,891

$   17,500

$   144,688

8.1%

8.9%

4Q11

4Q12

4Q13

Seattle – Lake Union

1551 Eastlake Avenue

65,342

52,141

117,483

74,914

8,000

34,569

117,483

71%

$   36,148

$   20,366

$     2,730

$     4,766

$     64,010

6.7%

6.7%

4Q11

4Q11

4Q13

Suburban and other redevelopment projects

18,461

326,262

344,723

211,388

55,270

78,065

344,723

77%

$   11,840

$ 151,650

$     7,504

$   37,590

$   208,584

Other – suburban and other redevelopment projects (4)

$     5,807

$    (5,807)

Redevelopment projects in North America

83,803

590,526

674,329

456,241

63,270

154,818

674,329

77%

$   53,795

$ 277,506

$   26,125

$   59,856

$   417,282

Total development and redevelopment projects in North America

183,497

1,477,782

1,661,279

1,185,107

63,270

412,902

1,661,279

75%

$ 132,935

$ 582,125

$   59,469

$ 219,409

$   993,938

(1)   As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.  Our Initial Stabilized Yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our contractual cash rents related to our value-added projects to increase over time.

(2)   The cash and GAAP Initial Stabilized Yields related to the development of 499 Illinois Street declined by approximately 0.3% and 0.2%, respectively, to allow for a slightly longer absorption period.  Despite this change, we still expect to achieve overall yields for the entire project (including the occupied portion of 409 Illinois) within our original expectations of 6.5%-7.0% and 7.2%-7.6% for cash and GAAP, respectively.

(3)   Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

(4)   As of the period end, some portion of the real estate basis associated with the rentable square feet under development or redevelopment was classified as in service because activities necessary to prepare the asset for its intended use were no longer in process.  In the near future, we anticipate recommencing activities necessary to prepare the asset for its intended use upon execution of leasing and final decisions related to design of each space.

Third Quarter Ended September 30, 2012, Financial and Operating Results

EARNINGS CALL INFORMATION

We will host a conference call on Monday, October 29, 2012, at 3:00 p.m. Eastern Time ("ET")/12:00 p.m. noon Pacific Time ("PT") that is open to the general public to discuss our financial and operating results for the three months and nine months ended September 30, 2012.  To participate in this conference call, dial (800) 447-0521 or (847) 413-3238 and confirmation code 33218271, shortly before 3:00 p.m. ET/12:00 p.m. noon PT.  The audio web cast can be accessed at: www.are.com, in the "For Investors" section.  A replay of the call will be available for a limited time from 5:30 p.m. ET/2:30 p.m. PT on Monday, October 29, 2012.  The replay number is (888) 843-7419 or (630) 652-3042 and the confirmation code is 33218271.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the third quarter ended September 30, 2012, are available in the "For Investors" section of our website at www.are.com.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed REIT, is the largest and leading investment-grade REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in every core life science cluster location including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

***********

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such forward-looking statements include, without limitation, statements regarding our 2012 earnings per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders − diluted, 2012 FFO per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders − diluted, net operating income, and net income, for the year ended December 31, 2012, and our projected sources and uses of capital in 2012.  Our actual results may differ materially from those projected in such forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC.  All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Statements of Income

(Dollars in thousands, except per share amounts)

(Unaudited)

Three Months Ended

Nine Months Ended

9/30/12

6/30/12

3/31/12

12/31/11

9/30/11

9/30/12

9/30/11

Revenues:

Rental

$       108,367

$       106,463

$       103,417

$       104,634

$       102,353

$       318,247

$       309,532

Tenant recoveries

34,448

32,172

32,386

33,031

33,226

99,006

95,270

Other income

2,640

9,381

2,629

1,584

2,475

14,650

4,178

Total revenues

145,455

148,016

138,432

139,249

138,054

431,903

408,980

Expenses:

Rental operations

44,614

42,359

40,911

41,553

40,859

127,884

118,014

General and administrative

12,485

12,309

10,358

10,601

10,289

35,152

30,528

Interest

17,094

17,922

16,227

14,757

14,273

51,243

48,621

Depreciation and amortization

47,176

51,276

42,326

39,762

38,747

140,778

113,326

Total expenses

121,369

123,866

109,822

106,673

104,168

355,057

310,489

Income from continuing operations before loss on early

    extinguishment of debt

24,086

24,150

28,610

32,576

33,886

76,846

98,491

Loss on early extinguishment of debt

(1,602)

(623)

(2,742)

(2,225)

(6,485)

Income from continuing operations

24,086

22,548

27,987

32,576

31,144

74,621

92,006

(Loss) income from discontinued operations:

Income from discontinued operations before

     impairment of real estate

4,018

 

3,093

2,924

2,886

2,799

10,035

8,873

Impairment of real estate

(9,799)

(994)

(9,799)

(994)

(Loss) income from discontinued operations, net

(5,781)

3,093

2,924

2,886

1,805

236

7,879

Gain on sale of land parcel

1,864

46

1,864

46

Net income

18,305

25,641

32,775

35,462

32,995

76,721

99,931

Net income attributable to noncontrolling interests

828

851

711

1,142

966

2,390

2,833

Dividends on preferred stock

6,471

6,903

7,483

7,090

7,089

20,857

21,267

Preferred stock redemption charge

5,978

5,978

Net income attributable to unvested restricted stock

     awards

360

271

235

270

278

866

818

Net income attributable to Alexandria Real Estate

     Equities, Inc.'s common stockholders

$         10,646

$         17,616

$         18,368

$         26,960

$         24,662

$         46,630

$         75,013

Earnings per share attributable to Alexandria Real Estate

     Equities, Inc.'s common stockholders – basic and

     diluted:

Continuing operations

$            0.26

$            0.24

$            0.25

$            0.39

$            0.37

$            0.75

$            1.15

Discontinued operations, net

(0.09)

0.05

0.05

0.05

0.03

0.14

Earnings per share – basic and diluted

$            0.17

$            0.29

$            0.30

$            0.44

$            0.40

$            0.75

$            1.29

Weighted average shares of common stock outstanding

        for calculating earnings per share attributable to

        Alexandria Real Estate Equities, Inc.'s common

        stockholders – basic

62,364,210

61,663,367

61,507,807

61,427,495

61,295,659

61,847,023

58,271,270

Dilutive effect of stock options

173

1,160

3,939

8,310

448

13,475

Weighted average shares of common stock outstanding

        for calculating earnings per share attributable to

        Alexandria Real Estate Equities, Inc.'s common

        stockholders – diluted

62,364,210

61,663,540

61,508,967

61,431,434

61,303,969

61,847,471

58,284,745

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Balance Sheets

(Dollars in thousands)

(Unaudited)

September 30,

June 30,

March 31,

December 31,

September 30,

2012

2012

2012

2011

2011

Assets

Investments in real estate, net

$          6,300,027

$          6,208,354

$          6,113,252

$          6,008,440

$          5,925,292

Cash and cash equivalents

94,904

80,937

77,361

78,539

73,056

Restricted cash

44,863

41,897

39,803

23,332

27,929

Tenant receivables

10,124

6,143

8,836

7,480

6,599

Deferred rent

160,914

155,295

150,515

142,097

132,954

Deferred leasing and financing costs, net

152,021

151,355

143,754

135,550

134,366

Investments

107,808

104,454

98,152

95,777

88,777

Other assets

94,356

93,304

86,418

82,914

66,583

Total assets

$          6,965,017

$          6,841,739

$          6,718,091

$          6,574,129

$          6,455,556

          Liabilities, Noncontrolling Interests, and Equity

Secured notes payable

$             719,350

$             719,977

$             721,715

$             724,305

$             760,882

Unsecured senior notes payable

549,794

549,783

550,772

84,959

84,484

Unsecured senior line of credit

413,000

379,000

167,000

370,000

814,000

Unsecured senior bank term loans

1,350,000

1,350,000

1,350,000

1,600,000

1,000,000

Accounts payable, accrued expenses, and tenant security deposits

376,785

348,037

323,002

325,393

330,044

Dividends payable

39,468

38,357

36,962

36,579

35,287

Preferred stock redemption liability

129,638

Total liabilities

3,448,397

3,385,154

3,279,089

3,141,236

3,024,697

Commitments and contingencies

Redeemable noncontrolling interests

15,610

15,817

15,819

16,034

15,931

Alexandria Real Estate Equities, Inc.'s stockholders' equity:

Series C Preferred Stock

129,638

129,638

Series D Convertible Preferred Stock

250,000

250,000

250,000

250,000

250,000

Series E Preferred Stock

130,000

130,000

130,000

Common stock

632

622

616

616

614

Additional paid-in capital

3,094,987

3,053,269

3,022,242

3,028,558

3,025,444

Accumulated other comprehensive loss

(19,729)

(37,370)

(23,088)

(34,511)

(32,202)

Alexandria Real Estate Equities, Inc.'s stockholders' equity

3,455,890

3,396,521

3,379,770

3,374,301

3,373,494

Noncontrolling interests

45,120

44,247

43,413

42,558

41,434

Total equity

3,501,010

3,440,768

3,423,183

3,416,859

3,414,928

Total liabilities, noncontrolling interests, and equity

$          6,965,017

$          6,841,739

$          6,718,091

$          6,574,129

$          6,455,556

 

ALEXANDRIA REAL ESTATE EQUITIES, INC. Funds From Operations and Adjusted Funds From Operations (Dollars in thousands, except per share amounts) (Unaudited)

The following table presents a reconciliation of net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders − basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders − diluted, FFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders − diluted for the periods below:

 

Three Months Ended

Nine Months Ended

9/30/12

6/30/12

3/31/12

12/31/11

9/30/11

9/30/12

9/30/11

Net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – basic

$          10,646

$          17,616

$          18,368

$          26,960

$          24,662

$          46,630

$          75,013

      Depreciation and amortization

48,173

52,355

43,405

40,966

39,990

143,933

117,060

      Gain on sale of real estate

(1,562)

(2)

(1,564)

      Impairment of real estate

9,799

994

9,799

994

      Gain on sale of land parcel

(1,864)

(46)

(1,864)

(46)

      Amount attributable to noncontrolling interests/unvested stock awards:

            Net income

1,188

1,122

946

1,412

1,244

3,256

3,651

            FFO

(1,148)

(1,133)

(1,156)

(1,539)

(1,580)

(3,452)

(4,877)

FFO attributable to Alexandria Real Estate Equities, Inc.'s common

      stockholders – basic

67,096

69,958

59,699

67,799

65,264

196,738

191,795

      Assumed conversion of 8.00% Unsecured Senior Convertible Notes

5

6

5

5

4

16

16

FFO attributable to Alexandria Real Estate Equities, Inc.'s common

      stockholders – diluted

67,101

69,964

59,704

67,804

65,268

196,754

191,811

      Realized gain on equity investment primarily related to one non-tenant life

            science entity

(5,811)

(5,811)

      Loss on early extinguishment of debt

1,602

623

2,742

2,225

6,485

      Preferred stock redemption charge

5,978

5,978

      Allocation to unvested restricted stock awards

35

(53)

(38)

(21)

(59)

FFO attributable to Alexandria Real Estate Equities, Inc.'s common

      stockholders – diluted, as adjusted

$          67,101

$          65,790

$          66,252

$          67,804

$          67,972

$        199,125

$        198,237

      Non-incremental revenue-enhancing capital expenditures:

       Building improvements

(935)

(594)

(210)

(675)

(550)

(1,739)

(1,856)

          Tenant improvements and leasing commissions

(1,844)

(2,148)

(2,019)

(6,083)

(2,119)

(6,011)